All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

GSK’s Aspen sale is SA’s biggest block

Pharmaceuticals firm GlaxoSmithKline disposed of a third of its stake in Aspen, a South African company, on Tuesday night, raising $700m through a block that was well supported before launch by wall-crossed accounts. It was South Africa’s largest ever block trade.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree